DIASORIN
Research DIASORIN (DIA.MI) on Bullrun: market cap EUR 3.75B, P/E 27.9, dividend yield 1.7%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerDIA.MI
- ExchangeMTAA
- CountryItaly
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyEUR
- Market capEUR 3.75B
- P/E27.9
- Dividend yield1.7%
- Financial periodQ2 2026
Valuation Snapshot
latest market cap is EUR 3.75B; P/E is 27.9; dividend yield is 1.7%.
Peer valuation comparison
Latest P/E is 27.91x versus a Healthcare sector median of 24.6x (13.5% above).
Latest dividend yield is 1.66% versus a Healthcare sector median of 1.84% (9.8% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | EUR 1.20B | EUR 150.04M | EUR 281.03M | 64.7% | 2.85 | EUR 165.80M | EUR 769.18M | EUR 1.58B |
| FY2024 | EUR 1.19B | EUR 187.06M | EUR 306.66M | 65.9% | 3.35 | EUR 344.27M | n/a | EUR 1.80B |
| FY2023 | EUR 1.15B | EUR 158.51M | EUR 266.20M | 64.6% | 2.87 | EUR 280.31M | n/a | EUR 1.54B |
| FY2022 | EUR 1.36B | EUR 240.11M | EUR 336.15M | 66.2% | 4.15 | EUR 241.78M | n/a | EUR 1.52B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-05 | EUR 3.75B | 27.9 | 1.7% | 1.3 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 1.3 EUR, yield 1.7%.
| Year | Dividends/share |
|---|---|
| FY2025 | 1.2 EUR |
| FY2024 | 1.15 EUR |
| FY2023 | 1.1 EUR |
| FY2022 | 1.05 EUR |
About DIASORIN
DiaSorin S.p.A. engages in research and development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, North America, and internationally. It provides various immunodiagnostic in the areas, including infectious diseases, gastrointestinal diseases, hepatitis and retroviruses, endocrinology, metabolic disorders, tumor markers, and oncology under LIAISON XL and LIAISON XS name.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is DIASORIN's market cap?
DIASORIN's market capitalization is EUR 3.75B.
What is DIASORIN's P/E ratio?
DIASORIN's price-to-earnings (P/E) ratio is 27.9.
Does DIASORIN pay a dividend?
DIASORIN has a dividend yield of 1.7%.
What does DIASORIN do?
DiaSorin S.p.A. engages in research and development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, North America, and internationally. It provides various immunodiagnostic in the areas, including infectious diseases, gastrointestinal diseases, hepatitis and retroviruses, endocrinology, metabolic disorders, tumor markers, and oncology under LIAISON XL and LIAISON XS name. The company also offers Simplexa, a congenital CMV direct kit, which detects cytomegalovirus DNA in saliva swab and urine specimens.